Novavax, Inc [NASDAQ: NVAX] stock went on a downward path that fall over -3.23% on Wednesday, amounting to a one-week price decrease of less than -6.37%.
Over the last 12 months, NVAX stock dropped by -10.45%. The one-year Novavax, Inc stock forecast points to a potential upside of 47.14. The average equity rating for NVAX stock is currently 2.22, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $1.17 billion, with 162.47 million shares outstanding and 148.12 million shares in the current float. Compared to the average trading volume of 5.38M shares, NVAX stock reached a trading volume of 4936821 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Novavax, Inc [NVAX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NVAX shares is $13.62 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NVAX stock is a recommendation set at 2.22. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for Novavax, Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on October 24, 2025. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on August 28, 2025, representing the official price target for Novavax, Inc stock. Previously, the target price had yet another raise to $7, while BofA Securities analysts kept a Underperform rating on NVAX stock.
NVAX Stock Performance Analysis:
Novavax, Inc [NVAX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.37. With this latest performance, NVAX shares dropped by -19.01% in over the last four-week period, additionally plugging by 20.81% over the last 6 months – not to mention a drop of -10.45% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NVAX stock in for the last two-week period is set at 35.95, with the RSI for the last a single of trading hit 0.41, and the three-weeks RSI is set at 0.43 for Novavax, Inc [NVAX]. The present Moving Average for the last 50 days of trading for this stock 8.38, while it was recorded at 7.36 for the last single week of trading, and 7.55 for the last 200 days.
Insight into Novavax, Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Novavax, Inc [NVAX] shares currently have an operating margin of 39.14% and a Gross Margin at 90.60%. Novavax, Inc’s Net Margin is presently recorded at 32.10%.
Novavax, Inc (NVAX) Capital Structure & Debt Analysis
Novavax, Inc (NVAX) Efficiency & Liquidity Metrics
Novavax, Inc (NVAX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Novavax, Inc. (NVAX) effectively leverages its workforce, generating an average of $358981.09 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.27% and a Quick Ratio of 2.24%, indicating strong ability to cover short-term liabilities.
NVAX Stock EPS
With the latest financial reports released by the company, Novavax, Inc posted -0.52/share EPS, while the average EPS was predicted by analysts to be reported at -0.51/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NVAX.
Novavax, Inc [NVAX] Institutonal Ownership Details
There are presently around $58.24%, or 63.82%% of NVAX stock, in the hands of institutional investors. The top three institutional holders of NVAX stocks are: VANGUARD GROUP INC with ownership of 14.08 million shares, which is approximately 9.4861%. BLACKROCK INC., holding 11.85 million shares of the stock with an approximate value of $$149.98 million in NVAX stocks shares; and BLACKROCK INC., currently with $$122.32 million in NVAX stock with ownership which is approximately 6.5118%.
